BioCentury
ARTICLE | Finance

Sowing season

Buysiders eyeing big cap clinical milestones in 2016 to seed next growth spurt

January 11, 2016 8:00 AM UTC

BUYSIDE VIEW XXIV

While the biotech sector's three-year rocket ride isn't likely to continue in 2016, fund managers are still anticipating a slew of high-profile milestones in the New Year. This year the emphasis is more on data than on approvals or launches as buysiders look ahead to the seeds for the next phase of growth...